Arkolith/Insider Trading/CMRA/Form 4/A

Sherblom James

DirectorComera Life Sciences Holdings, Inc. (CMRA) · full profile →Form 4/A · filed Feb 14, 2023
Net Buying
Open-Market Buys
$100K
Open-Market Sells
$0
Net Open-Market Flow
$100K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 4, 2023Buy(P)81K$1.23$100K452K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 4, 2023Buy(P)81K$0.25$20K81K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001062993-23-003511) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML